Veradigm Gross Margin 2010-2022 | MDRX
Current and historical gross margin for Veradigm (MDRX) over the last 10 years. The current gross profit margin for Veradigm as of December 31, 2022 is %.
| Veradigm Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2022-12-31 | $0.59B | $0.31B | 52.12% |
| 2022-09-30 | $0.60B | $0.32B | 52.32% |
| 2022-06-30 | $0.60B | $0.30B | 50.75% |
| 2022-03-31 | $0.59B | $0.29B | 49.74% |
| 2021-12-31 | $0.58B | $0.28B | 48.79% |
| 2021-09-30 | $-0.14B | $0.06B | -43.57% |
| 2021-06-30 | $0.08B | $0.13B | 155.56% |
| 2021-03-31 | $0.31B | $0.20B | 63.43% |
| 2020-12-31 | $0.56B | $0.27B | 47.66% |
| 2020-09-30 | $1.43B | $0.48B | 33.75% |
| 2020-06-30 | $1.51B | $0.52B | 34.66% |
| 2020-03-31 | $1.58B | $0.57B | 35.93% |
| 2019-12-31 | $1.63B | $0.61B | 37.38% |
| 2019-09-30 | $1.63B | $0.62B | 37.91% |
| 2019-06-30 | $1.62B | $0.62B | 38.38% |
| 2019-03-31 | $1.62B | $0.61B | 37.83% |
| 2018-12-31 | $1.62B | $0.62B | 38.47% |
| 2018-09-30 | $1.52B | $0.60B | 39.71% |
| 2018-06-30 | $1.53B | $0.63B | 40.83% |
| 2018-03-31 | $1.52B | $0.64B | 42.09% |
| 2017-12-31 | $1.50B | $0.63B | 42.28% |
| 2017-09-30 | $1.55B | $0.69B | 44.19% |
| 2017-06-30 | $1.49B | $0.65B | 43.47% |
| 2017-03-31 | $1.45B | $0.63B | 43.26% |
| 2016-12-31 | $1.39B | $0.60B | 43.40% |
| 2016-09-30 | $1.47B | $0.64B | 43.44% |
| 2016-06-30 | $1.43B | $0.63B | 43.68% |
| 2016-03-31 | $1.40B | $0.60B | 43.13% |
| 2015-12-31 | $1.39B | $0.58B | 41.89% |
| 2015-09-30 | $1.38B | $0.56B | 40.74% |
| 2015-06-30 | $1.37B | $0.54B | 39.40% |
| 2015-03-31 | $1.37B | $0.54B | 39.14% |
| 2014-12-31 | $1.38B | $0.55B | 39.58% |
| 2014-09-30 | $1.39B | $0.55B | 39.44% |
| 2014-06-30 | $1.37B | $0.54B | 39.50% |
| 2014-03-31 | $1.37B | $0.54B | 39.39% |
| 2013-12-31 | $1.37B | $0.53B | 38.89% |
| 2013-09-30 | $1.37B | $0.53B | 38.75% |
| 2013-06-30 | $1.40B | $0.56B | 40.10% |
| 2013-03-31 | $1.43B | $0.58B | 40.87% |
| 2012-12-31 | $1.45B | $0.61B | 41.88% |
| 2012-09-30 | $1.48B | $0.65B | 43.53% |
| 2012-06-30 | $1.49B | $0.65B | 43.78% |
| 2012-03-31 | $1.47B | $0.66B | 44.91% |
| 2011-12-31 | $1.44B | $0.67B | 46.12% |
| 2011-09-30 | $1.37B | $0.64B | 46.36% |
| 2011-06-30 | $1.25B | $0.60B | 47.84% |
| 2011-03-31 | $1.08B | $0.54B | 49.35% |
| 2010-09-30 | $0.62B | $0.33B | 53.97% |
| 2010-06-30 | $0.56B | $0.31B | 56.04% |
| 2010-03-31 | $0.53B | $0.30B | 56.66% |
| 2010-02-28 | $0.51B | $0.29B | 55.84% |
| 2009-09-30 | $0.49B | $0.26B | 53.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.525B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Phreesia (PHR) | United States | $1.808B | 0.00 |
| Enovis (ENOV) | United States | $1.771B | 9.36 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.140B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Standard BioTools (LAB) | United States | $0.474B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |